In a 99.3 kg (BMI 40) patient with type 2 diabetes on prednisone 40 mg daily and NPH insulin 15 U with a 1 U:10 g carbohydrate‑to‑insulin ratio and a medium correction factor, whose glucose readings are 237 mg/dL at 8 am, 215 mg/dL at noon, 255 mg/dL at 4 pm, 270 mg/dL at 9 pm, and 290 mg/dL at 1 am, should I start insulin glargine (Lantus) or adjust the NPH carbohydrate ratio and correction factor?

Switch to Morning NPH Dosing for Steroid-Induced Hyperglycemia

For this patient on prednisone 40 mg with persistently elevated blood glucose throughout the day and night, you should switch from the current NPH regimen to morning-dosed NPH insulin, significantly increase the total daily insulin dose, and aggressively uptitrate the carbohydrate ratio and correction scale. The current 15 units of NPH is grossly inadequate for steroid-induced hyperglycemia at this prednisone dose.

Why Morning NPH is Superior for Steroid-Induced Hyperglycemia

The 2025 ADA Standards specifically recommend "dosing NPH in the morning for steroid-induced hyperglycemia" 1. This is critical because:

• Prednisone causes hyperglycemia predominantly between midday and midnight 2, matching NPH's peak action when dosed in the morning
• Your patient's glucose pattern confirms this: 237 mg/dL at 8 am rising progressively to 290 mg/dL at 1 am
• Evening/bedtime NPH would peak during sleep, causing nocturnal hypoglycemia risk while undertreating daytime hyperglycemia
• Morning NPH aligns insulin action with the glucocorticoid-induced glucose excursion pattern

Aggressive Insulin Dose Escalation Required

Your current total daily dose is dangerously inadequate. For a 99.3 kg patient on prednisone 40 mg:

Initial NPH dosing should be 0.5 units per mg of prednisone equivalent dose 3. This means:

• Target: 20 units NPH in the morning (0.5 units/mg × 40 mg prednisone)
• This is the minimum starting point; many patients require more

Alternative weight-based calculation:

• At 0.5 units/kg for steroid-induced hyperglycemia: approximately 50 units total daily insulin (0.5 × 99.3 kg)
• Split as 50% basal (25 units NPH morning) and 50% prandial

The evidence shows patients achieving euglycemia had median NPH doses of 0.5 units/mg prednisone equivalent versus 0.4 units/mg in those who failed 3.

Specific Insulin Regimen Recommendation

Morning NPH-based regimen:

• NPH 25 units every morning (before breakfast)
• Rapid-acting insulin with meals: Start 8-10 units with each meal
• Tighten carbohydrate ratio: Change from 1:10 to 1:5 carb ratio (1 unit per 5 grams carbohydrate)
• Aggressive correction scale: Use high-dose correction (subtract 30-40 mg/dL per unit, not the typical 50 mg/dL)

Titration Algorithm

Increase NPH by 4 units every 2-3 days until fasting and daytime glucose consistently <180 mg/dL 1:

• Day 1-2: 25 units morning NPH
• Day 3-4: 29 units if glucose remains >180 mg/dL
• Day 5-6: 33 units if needed
• Continue until glucose controlled

For prandial insulin: Increase by 2 units per meal every 2-3 days based on pre-meal and 2-hour post-meal readings.

Why NOT Switch to Lantus

While switching to glargine (Lantus) is an option, it is not the optimal choice for steroid-induced hyperglycemia:

1. Timing mismatch: Glargine provides flat 24-hour coverage 4, but prednisone causes daytime-predominant hyperglycemia 2
2. Equivalent efficacy: Research shows NPH and glargine achieve similar glycemic control in steroid-induced hyperglycemia (mean daily glucose 167 vs 165 mg/dL, p=0.79) 5
3. Lower insulin requirements with NPH: The NPH cohort required significantly less insulin (0.27 vs 0.34 units/kg basal, p=0.04) 5
4. Guideline preference: ADA explicitly recommends morning NPH for steroid-induced hyperglycemia 1

If you were to switch to Lantus, the FDA label recommends 80% of total NPH dose 4, but this would still require massive dose escalation from your current 15 units.

Critical Pitfalls to Avoid

Do not continue the current inadequate dosing. Your patient has blood glucose readings of 237-290 mg/dL consistently—this represents severe uncontrolled hyperglycemia requiring immediate aggressive intervention. The 2025 ADA guidelines state that with glucose ≥300 mg/dL, intensive insulin therapy is essential 1.

Do not fear hypoglycemia at higher doses. Research shows similar hypoglycemia rates between NPH cohorts despite different dosing intensities (0.12 vs 0.10 episodes/day, p=0.77) 5. The real danger is prolonged hyperglycemia causing acute complications, infections, and poor wound healing—especially relevant given the immunosuppressive effects of prednisone.

Do not simply adjust the carb ratio and correction scale without increasing basal insulin. The progressive rise in glucose from morning (237) to overnight (290) indicates inadequate basal coverage, not just prandial insulin deficiency.

Monitoring and Safety

• Check fasting glucose daily to titrate morning NPH
• Check pre-meal and 2-hour post-meal glucose to adjust prandial insulin
• Target fasting glucose: 100-130 mg/dL
• Target pre-meal glucose: 100-140 mg/dL
• Target 2-hour post-meal: <180 mg/dL

For hypoglycemia (<70 mg/dL): reduce corresponding insulin dose by 10-20% 1.

Given this patient's BMI of 40, they may require doses at the higher end of recommendations. Research shows obese patients (BMI ≥30) achieve greater A1C reduction with insulin therapy and may need higher doses 6.